3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / financial year ended 31st March, 2026 and to discuss the matter of recommendation of dividend ,if any, \r\nfor the financial year ended 31st March, 2026.